Saturday, 7 November 2026European Markets

IMERYS, VICAT, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Building Materials Industry.

Loading stream...

(vianews) - imerys (nk.pa) is among this list of stock assets with the highest dividend rate and return on equity on the building materials industry.

financial asset price forward dividend yield return on equity
imerys (nk.pa) €30.66 5.85% 3.79%
vicat (vct.pa) €31.35 5.65% 6.85%
titan cement (titc.br) €16.60 3.6% 12.21%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. imerys (nk.pa)

5.85% forward dividend yield and 3.79% return on equity

imerys s.a. provides mineral-based specialty solutions for various industries worldwide. the company operates through performance minerals and high temperature materials and solutions segments. it provides additives for interior decorative paints, as well as marine protection, facade coating, can coating; and adhesives and sealants. in addition, the company offers minerals for technical ceramics and traditional ceramics comprising floor and wall tiles, large slabs, sanitaryware, and tableware; and components for the production of high purity silicon metal for used to manufacture aluminum alloys, electronics, and solar panels, as well as for construction industry, such as insulation ceiling tiles. further, it provides functional additives for plastics and thermoset for use in construction and infrastructure industries; fillers and coatings for board and packaging applications; filtration agents for liquids and blood plasma; and graphite and carbon-based solutions for lithium-ion and alkaline batteries, polymers, fuel cells, carbon brushes, and others. additionally, the company offers refractory minerals and solutions for high-temperature processes; alumina and zirconia for abrasives; and high-performance binders for dry mix mortars and floor screeds in the construction industry. it serves automotive and transportation, consumer and health care, energy and electronics, industry and equipment, iron, and steel industries. the company was incorporated in 1880 and is headquartered in paris, france. imerys s.a. is a subsidiary of belgian securities bv.

earnings per share

as for profitability, imerys has a trailing twelve months eps of €1.47.

pe ratio

imerys has a trailing twelve months price to earnings ratio of 20.86. meaning, the purchaser of the share is investing €20.86 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.79%.

yearly top and bottom value

imerys's stock is valued at €30.66 at 07:40 est, way under its 52-week high of €43.22 and way above its 52-week low of €25.42.

dividend yield

according to morningstar, inc., the next dividend payment is on may 15, 2023, the estimated forward annual dividend rate is 1.5 and the estimated forward annual dividend yield is 5.85%.

more news about imerys.

2. vicat (vct.pa)

5.65% forward dividend yield and 6.85% return on equity

vicat s.a., together with its subsidiaries, engages in the production and sale of cement, ready-mixed concrete, and aggregates for construction industry. the company operates in three segments: cement, concrete & aggregates, and other products & services. the cement segment offers various cement products for the general contractors, such as concrete mixers, manufacturers of precast concrete products, construction and public works contractors, local authorities, residential property developers or master masons, and construction material wholesalers or retail chains. the concrete & aggregates segment provides ready-mixed concrete comprising standard and special concrete for the construction and public works contractors, including construction groups, house building companies, farmers, or private individuals; and aggregates, such as sands and gravel products for the ready-mixed concrete and precast concrete products manufacturers. the other products & services segment is involved in the transportation of cement, ready-mixed concrete, and aggregates; provision of construction chemicals for use in exterior wall coatings, mortar and traditional concretes, tiling adhesives, and thermal insulation products, as well as for the products used to repair floors and walls; and production of specialty papers and paper bags for the agro-food, chemical, and construction sectors. it operates in france, switzerland, italy, the united states, brazil, india, kazakhstan, turkey, egypt, senegal, mali, and mauritania. vicat s.a. was incorporated in 1853 and is headquartered in l'isle-d'abeau, france.

earnings per share

as for profitability, vicat has a trailing twelve months eps of €3.84.

pe ratio

vicat has a trailing twelve months price to earnings ratio of 8.16. meaning, the purchaser of the share is investing €8.16 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.85%.

dividend yield

as maintained by morningstar, inc., the next dividend payment is on apr 25, 2023, the estimated forward annual dividend rate is 1.65 and the estimated forward annual dividend yield is 5.65%.

more news about vicat.

3. titan cement (titc.br)

3.6% forward dividend yield and 12.21% return on equity

titan cement international s.a., together with its subsidiaries, produces, distributes, and trades in a range of construction materials in greece and western europe, north america, southeastern europe, the eastern mediterranean, and internationally. the company provides cement; ready-mix concrete; aggregates and coarse materials, including sand, gravel, crushed stone, and recycled concrete; and other building materials, such as dry mortars, building blocks, fly ash, and other concrete products for the construction of roads, bridges, airports, hospitals, schools, residential housing, commercial buildings, and social projects. it is also involved in the import and distribution of cement; processing of fly ash; sale of fly ash processing equipment; quarries; real estate brokerage services; engineering design services for solid and liquid waste facilities; and alternative fuels. in addition, the company provides trading, technical and business, port, financial, preventing maintenance, insurance, and transportation services; owns and develops real estate properties; rents and leases machines, equipment, and material goods; and designs, manufactures, and markets proprietary separation equipment for dry powders. titan cement international s.a. was founded in 1902 and is based in brussels, belgium.

earnings per share

as for profitability, titan cement has a trailing twelve months eps of €2.42.

pe ratio

titan cement has a trailing twelve months price to earnings ratio of 6.86. meaning, the purchaser of the share is investing €6.86 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.21%.

more news about titan cement.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com